Among the growth factors potentially involved in the migratory capability of GBM, the most studied is the EGF, since its receptor has been demonstrated to be over-expressed or mutated in a large percentage (40%) of glioblastomas [14]. This evidence concerns the gene EGF and glioblastoma.